Alpha-tocopherol and Alzheimer's disease [3] (multiple letters)

New England Journal of Medicine

Volumn 337, Issue 8, 1997, Pages 572-573

  Pincus, M M ^a   Kilander, L ^a   Ohrvall, M ^a   Sano, M ^a   Thomas, R G ^a   Thal, L J ^a  

^a NEW YORK METHODIST HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA TOCOPHEROL; PLACEBO; SELEGILINE;

ALZHEIMER DISEASE; CLINICAL TRIAL; COGNITION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; EDUCATION; HUMAN; LETTER; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; AGED; BLOOD; DRUG COMBINATION; DRUG EFFECT; EDUCATIONAL STATUS; MALE; NOTE; EPIDEMIOLOGY; PROPORTIONAL HAZARDS MODEL; SURVIVAL;

AGED; ALZHEIMER DISEASE; COGNITION; DRUG THERAPY, COMBINATION; EDUCATIONAL STATUS; HUMANS; MALE; SELEGILINE; VITAMIN E; BIAS (EPIDEMIOLOGY); PROPORTIONAL HAZARDS MODELS; SURVIVAL ANALYSIS;

EID: 0030746330     PISSN: 00284793     EISSN: None     Source Type: Journal    
DOI: 10.1056/NEJM199708213370814     Document Type: Letter

References (3)